Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (50)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Brink, M.
Right arrow Articles by van den Brandt, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brink, M.
Right arrow Articles by van den Brandt, P. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 24, No. 4, 703-710, April 2003
© 2003 Oxford University Press

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study

Mirian Brink1,4, Anton F.P.M. de Goeij2, Matty P. Weijenberg1, Guido M.J.M. Roemen2, Marjolein H.F.M. Lentjes2, Marco M.M. Pachen2, Kim M. Smits1, Adriaan P. de Bruïne2, R. Alexandra Goldbohm3 and Piet A. van den Brandt1

1 Nutrition and Toxicology Research Institute Maastricht (nutrim), Department of Epidemiology, Maastricht University, PO Box 616, 6200 MD, Maastricht
2 Research Institute Growth and Development (GROW), Department of Pathology, Maastricht University, Maastricht
3 TNO Nutrition and Food Research, PO Box 360, 3700 AJ Zeist, The Netherlands

4 To whom correspondence should be addressed Email: m.brink{at}epid.unimaas.nl

Activation of K-ras oncogene has been implicated in colorectal carcinogenesis, being mutated in 30–60% of the adenocarcinomas. In this study, 737 incident colorectal cancer (CRC) patients, originating from 120 852 men and women (55–69 years at baseline) participating in the Netherlands Cohort Study (NLCS), were studied in order to evaluate subgroups with respect to K-ras mutation status. Mutation analysis of the exon 1 fragment of the K-ras oncogene, spanning codons 8–29, was performed on archival colorectal adenocarcinoma samples of all patients using macrodissection, nested PCR and direct sequencing of purified fragments. The method of mutation detection was validated by the confirmation of reported K-ras status in CRC cell lines, a good correlation between fresh-frozen and routinely fixed, paraffin-embedded tissue, a detection limit of 5% mutated DNA and a good reproducibility. Various types of K-ras mutations were evaluated with respect to tumour sub-localization, Dukes' stage and tumour differentiation. In 37% (271/737) of the patients, the exon 1 fragment of K-ras gene was found to be mutated. The predominant mutations are G>A transitions and G>T transversions, and codons 12 and 13 are the most frequently affected codons. Patients with a rectal tumour were found to have the highest frequency of G>T transversions as compared with patients with a colon or rectosigmoid tumour. This difference appeared to be confined to women with a rectal tumour harbouring G>T transversions. No significant differences were observed for Dukes' stage with respect to types of K-ras mutation, which does not support direct involvement of the K-ras oncogene in adenocarcinoma progression. The equal distribution of K-ras mutations among cases with or without a family history of colorectal cancer argues against an important role for this mutation in familial colorectal cancer, and could imply that K-ras mutations are more probably involved in environmental mechanisms of colorectal carcinogenesis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
E. E. Mancl, J. M. Kolesar, and L. C. Vermeulen
Clinical and economic value of screening for Kras mutations as predictors of response to epidermal growth factor receptor inhibitors
Am. J. Health Syst. Pharm., December 1, 2009; 66(23): 2105 - 2112.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. He, L. J. Van't Veer, I. Mikolajewska-Hanclich, M.-L. F. van Velthuysen, E. C.M. Zeestraten, I. D. Nagtegaal, C. J.H. van de Velde, and C. A.M. Marijnen
PIK3CA Mutations Predict Local Recurrences in Rectal Cancer Patients
Clin. Cancer Res., November 15, 2009; 15(22): 6956 - 6962.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
S. Lorenzen, T. Schuster, R. Porschen, S.-E. Al-Batran, R. Hofheinz, P. Thuss-Patience, M. Moehler, P. Grabowski, D. Arnold, T. Greten, et al.
Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie
Ann. Onc., October 1, 2009; 20(10): 1667 - 1673.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
R. PALMIROTTA, A. SAVONAROLA, V. FORMICA, G. LUDOVICI, G. DEL MONTE, M. ROSELLI, and F. GUADAGNI
A Novel K-ras Mutation in Colorectal Cancer. A Case Report and Literature Review
Anticancer Res, August 1, 2009; 29(8): 3369 - 3374.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
V. Melotte, M. H. F. M. Lentjes, S. M. van den Bosch, D. M. E. I. Hellebrekers, J. P. J. de Hoon, K. A. D. Wouters, K. L. J. Daenen, I. E. J. M. Partouns-Hendriks, F. Stessels, J. Louwagie, et al.
N-Myc Downstream-Regulated Gene 4 (NDRG4): A Candidate Tumor Suppressor Gene and Potential Biomarker for Colorectal Cancer
J Natl Cancer Inst, July 1, 2009; 101(13): 916 - 927.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
S. de Vogel, M. P. Weijenberg, J. G. Herman, K. A. D. Wouters, A. F. P. M. de Goeij, P. A. van den Brandt, A. P. de Bruine, and M. van Engeland
MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events
Ann. Onc., July 1, 2009; 20(7): 1216 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. M.E.I. Hellebrekers, M. H.F.M. Lentjes, S. M. van den Bosch, V. Melotte, K. A.D. Wouters, K. L.J. Daenen, K. M. Smits, Y. Akiyama, Y. Yuasa, S. Sanduleanu, et al.
GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer
Clin. Cancer Res., June 15, 2009; 15(12): 3990 - 3997.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. de Vogel, B. W.C. Bongaerts, K. A.D. Wouters, A. D.M. Kester, L. J. Schouten, A. F.P.M. de Goeij, A. P. de Bruine, R. A. Goldbohm, P. A. van den Brandt, M. van Engeland, et al.
Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer
Carcinogenesis, September 1, 2008; 29(9): 1765 - 1773.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
A. Kuijsten, P. C. H. Hollman, H. C. Boshuizen, M. N. C. P. Buijsman, P. van 't Veer, F. J. Kok, I. C. W. Arts, and H. B. Bueno-de-Mesquita
Plasma Enterolignan Concentrations and Colorectal Cancer Risk in a Nested Case-Control Study
Am. J. Epidemiol., March 15, 2008; 167(6): 734 - 742.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Sanchez-de-Abajo, M. de la Hoya, M. van Puijenbroek, A. Tosar, J.A. Lopez-Asenjo, E. Diaz-Rubio, H. Morreau, and T. Caldes
Molecular Analysis of Colorectal Cancer Tumors from Patients with Mismatch Repair Proficient Hereditary Nonpolyposis Colorectal Cancer Suggests Novel Carcinogenic Pathways
Clin. Cancer Res., October 1, 2007; 13(19): 5729 - 5735.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S. de Vogel, M. van Engeland, M. Luchtenborg, A. P. de Bruine, G. M. J. M. Roemen, M. H. F. M. Lentjes, R. A. Goldbohm, P. A. van den Brandt, A. F. P. M. de Goeij, and M. P. Weijenberg
Dietary Folate and APC Mutations in Sporadic Colorectal Cancer
J. Nutr., December 1, 2006; 136(12): 3015 - 3021.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
M Nielsen, J W Poley, S Verhoef, M van Puijenbroek, M M Weiss, G T Burger, C J Dommering, H F A Vasen, E J Kuipers, A Wagner, et al.
Duodenal carcinoma in MUTYH-associated polyposis
J. Clin. Pathol., November 1, 2006; 59(11): 1212 - 1215.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. G. Einspahr, M. E. Martinez, R. Jiang, C.-H. Hsu, A. K. Bhattacharrya, D. J. Ahnen, E. T. Jacobs, P. S. Houlihan, C. R. Webb, D. S. Alberts, et al.
Associations of Ki-ras Proto-oncogene Mutation and p53 Gene Overexpression in Sporadic Colorectal Adenomas with Demographic and Clinicopathologic Characteristics.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1443 - 1450.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Shahrzad, L. Quayle, C. Stone, C. Plumb, S. Shirasawa, J. W. Rak, and B. L. Coomber
Ischemia-Induced K-ras Mutations in Human Colorectal Cancer Cells: Role of Microenvironmental Regulation of MSH2 Expression
Cancer Res., September 15, 2005; 65(18): 8134 - 8141.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
A Conlin, G Smith, F A Carey, C R Wolf, and R J C Steele
The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma
Gut, September 1, 2005; 54(9): 1283 - 1286.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
M. Luchtenborg, M. P. Weijenberg, E. Kampman, G. N. van Muijen, G. M. J. M. Roemen, M. P. A. Zeegers, R. A. Goldbohm, P. van 't Veer, A. F. P. M. de Goeij, and P. A. van den Brandt
Cigarette Smoking and Colorectal Cancer: APC Mutations, hMLH1 Expression, and GSTM1 and GSTT1 Polymorphisms
Am. J. Epidemiol., May 1, 2005; 161(9): 806 - 815.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J.-H. Park, I.-J. Kim, H. C. Kang, Y. Shin, H.-W. Park, S.-G. Jang, J.-L. Ku, S.-B. Lim, S.-Y. Jeong, and J.-G. Park
Oligonucleotide Microarray-Based Mutation Detection of the K-ras Gene in Colorectal Cancers with Use of Competitive DNA Hybridization
Clin. Chem., September 1, 2004; 50(9): 1688 - 1691.
[Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Brink, M. P. Weijenberg, A. F. P. M. de Goeij, L. J. Schouten, F. D. H. Koedijk, G. M. J. M. Roemen, M. H. F. M. Lentjes, A. P. de Bruine, R.A. Goldbohm, and P. A. van den Brandt
Fat and K-ras mutations in sporadic colorectal cancer in The Netherlands Cohort Study
Carcinogenesis, September 1, 2004; 25(9): 1619 - 1628.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Luchtenborg, M. P. Weijenberg, G. M. J. M. Roemen, A. P. de Bruine, P. A. van den Brandt, M. H. F. M. Lentjes, M. Brink, M. van Engeland, R. A. Goldbohm, and A. F. P. M. de Goeij
APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study
Carcinogenesis, July 1, 2004; 25(7): 1219 - 1226.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.